• 1995

Company Description

Omrix Biopharmaceuticals develops, manufactures, and markets biological products for the biosurgical and immunotherapy markets.

Omrix Biopharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets biological products for the biosurgical and immunotherapy markets. The company, formerly known as Omrix Biopharmaceuticals S.A., was founded in 1995 and is headquartered in New York. As of December 26, 2008, Omrix Biopharmaceuticals, Inc. operates as a subsidiary of Johnson & Johnson.